Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
76 Cards in this Set
- Front
- Back
Viral hepatitis that is a sudden illness with a mild to severe course followed by complete resolution
|
acute viral hepatitis
|
|
Prolonged course of active disease or silent asymptomatic infection
|
chronic viral hepatitis
|
|
Which hepatitis viridae can cause chronic hepatitis?
|
HBV, HCV, HDV
|
|
T/F Hepatitis viridae are all RNA viruses
|
F. HBV is DNA.
|
|
A) Viral hepatitis causes elevations in what enzymes?
B) Why? |
A) ALT and AST
B) The hepatocytes produce these transaminases. The hepatocytes are what hepatitis infects. |
|
A) What enzymes would be elevated with a gallstone?
B) Why? |
A) Alkaline phosphatase, GGT, and bilirubin
B) The stone would be blocking the bile duct. The cells lining the bile canaliculi produces these enzymes and carry bilirubin. |
|
What family is HAV in?
|
picornaviridae
|
|
What kind of nucleic acid does HAV have?
|
(+) single-stranded RNA
|
|
How long is HAV incubation period?
|
15-40 days (about 1 month)
2-6 weeks |
|
What characterizes the pre-icteric phase of viral hepatitis?
|
(Means preceding jaundice).
Pruritus, rash. Start to feel generally bad. |
|
For many viral illnesses, which of AST or ALT will be higher?
|
ALT
|
|
An increase in what three things characterize an acute viral hep infection?
|
1) ALT (and AST)
2) IgM 3) Viremia |
|
Periportal Infiltration: defn
|
On histology, an acute accumulation of neutrophils and monocytes around the portals
|
|
What is bridging necrosis and when is it seen?
|
confluent necrosis linking terminal venules to portal tracts.
Seen in viral hepatitis |
|
Route of HAV transmission
|
fecal/oral
|
|
T/F HAV is associated with chronic disease/cirrhosis
|
F
|
|
T/F There is no carrier state in HAV
|
T
|
|
Before the onset of symptoms, for how long is HAV secreted in stools?
|
2 weeks
|
|
What is the acute phase antibody?
|
IgM
|
|
What histological changes are seen in cirrhosis?
|
Lots of space between hepatocytes and fibrosis
|
|
Which age group is more likely to show jaundice in HAV?
|
>14 years
|
|
Complications of HAV
|
Fulminant hepatitis Cholestatic hepatitis Relapsing hepatitis
|
|
How is acute infection of HAV dxed?
|
Detection of HAV-<b>IgM</b> in serum by enzyme immune linked assay.
|
|
How is past infection of HAV dxed?
|
Detection of HAV-<b>IgG </b>(the "convalescent" phase antibody) in serum by enzyme immune linked assay.
|
|
Prophylaxis against Hep A
|
1) Vaccine
2) Immune serum globulin/gamma globulin given to infected person's household contacts |
|
What kind of virus is Hep B?
|
Hepadnaviridae.
Large virus. Enveloped icosahedral capsid and (partially) dsDNA that's circular. There are two ss regions. |
|
What are filamentous structures composed of the envelope and some capsid proteins that have disassociated from the intact virion?
|
heptatis B surface antigen (HBsAg)
|
|
T/F Antibodies against HBsAg are protective
|
T
|
|
What is the other important Hep B antigen?
|
HBcAg (hep B core antigen)
|
|
T/F Antibodies against HBcAg are protective
|
F
|
|
What is HBeAg? What is it a marker for?
|
Soluble component of the core Hep B virus that is released during active infection and viral growth. It's a cleavage product of the viral core structure polypeptide (HBcAG).
<b>It is a marker for active disease and highly infectious state.</b> |
|
How is HBV transmitted?
|
blood-to-blood contact (parenteral)
|
|
fulminant hepatitis
|
severe acute hepatitis with rapid destruction of the liver
|
|
What are the disease states caused by hepatitis B?
|
1) Acute hepatitis
2) Fulminant hepatitis 3) Chronic hepatitis |
|
What are the types of chronic hepatitis B?
|
1) Asymptomatic carrier: Never develops antibodies against HBsAg (anti HBsAg antibodies) and harbors virus without liver injury.
2) Chronic-persistent hepatitis (low grade "smoldering" hepatitis) 3) Chronic active hepatitis: acute hep state that lasts longer than 6-12 months 4) Coinfection with HDV |
|
What appears to cause liver injury?
|
Cell-mediated attack on HBV. Viral antigens on surface of infected hepatocytes are targets for cytotoxic T cells
|
|
Which antibody against HBV is protective?
|
against surface antigen.
HBsAG |
|
What is primary hepatocellular carcinoma a complication of?
|
HBV chronic infection.
|
|
What can be said about the presence of HBsAg?
|
The presence of HBsAg in the blood means disease. Can be acute or chronic
|
|
What can be said about the presence of anti HBsAg antibodies?
|
HBsAg has disappeared. Person is <b>immune.</b>
|
|
What can be said about the presence of
A) IgM anti-HBcAg B) IgG anti-HBcAg |
A) New infection
B) Old infection |
|
What can be said about the presence of
A) HBeAg b) anti-HbeAg antibodies |
A) High infectivity - active disease
B) Low infectivity |
|
When will anti-HBeAg antibodies start to develop?
|
6 months
|
|
What is in the vaccine for HBV?
|
The surface envelop and proteins; HBsAg
|
|
T/F HBV is a retrovirus
|
F. It does use reverse transcription.
|
|
What is the relationship between HBV and malaria?
|
co-infection can result in tumors
|
|
What happens after the HBV virus membrane fuses with host cell's membrane?
|
It releases mRNA and core proteins into cytoplasm. Host proteins, Chaperones, transfer viral genomic DNA to cell nucleus
|
|
Major behaviors associated with transmission of HBV
|
sex, IV drug use
|
|
What is the Ig prophylaxis against Hep B?
|
1) Pre-exposure: Vaccine
2) Post-exposure: H-BIG (Hepatitis B Immune Globulin) + Vaccine |
|
Detection of ______ in blood or serum indicates that serum or blood contains the HBvirus, but says nothing about whether it's acute or chronic
|
HBsAg
|
|
T/F There is a high amount of HBV detectable in semen, vaginal fluid, and saliva
|
F. Moderate amount in these fluids.
|
|
Indicates that infection is active, that complete virions are in the blood, and that the patient is highly infectious
|
Hepatitis B e antigen (HBeAg)
|
|
Appears late during incubation period and disappears when hepatic disease begins
(HBV) |
DNA polymerase
|
|
Indicates immunity to HBV
Appears in patients who spontaneously recover from HBV infection Appearance during viremia results in immune complex disease, polyarteritis nodosa, and membranous glomerulonephritis |
Anti-HBs antibody
|
|
Leading cause of chronic hepatitis in US
|
HCV
|
|
What %age of those with exposure to HCV go on to develop chronic hepatitis?
|
up to 85%
|
|
Leading indication for liver transplantation in the US
|
Chronic Hep C
|
|
Primary means of HCV infection
|
IV drug use
|
|
Incubation period for HCV
|
2-20 weeks with avg of 6-7 weeks
|
|
T/F Acute infection of HCV is usually asymptomatic
|
T
|
|
_______% of patients with HCV will go on to develop chronic hepatitis; ___% will develop cirrhosis
|
85%; 20%
|
|
Classification of HCV
|
Flavivirus
|
|
How is HCV diagnosed?
|
testing for anti-HCV antibodies (detectable within 6-8 weeks, remain positive thereafter)
|
|
What changes occur in the levels of ALT over chronic HCV infection?
|
Levels of ALT fluctuate
|
|
How is HDV transmitted? What is special about it?
|
Parenterally. Can only replicate with help of HBV
|
|
HDV is also called
|
δ agent
|
|
T/F Antibodies against HBsAg will be protective against both HDV and HBV
|
T
|
|
What type of genome does HDV/δ agent have?
|
Circular RNA
|
|
What is superinfection?
|
When HDV infects a person with a chronic HBV infection.
This results in acute hepatitis in patient already chronically infected with HBV, leading to a very severe illness. Higher incidence of fulminant hepatitis,cirrhosis. |
|
T/F The patient with chronic HBV cannot make Anti-HBsAg and so remains chronically infected with both HBV and HDV
|
T
|
|
Tx of HDV
|
None. Best is to control HBV infection
|
|
Pre or postexposure prophylaxis to prevent HBV infection: does this work in HBV/HDV coinfection or superinfection?
|
Coinfection (when they're acquired at the same time) only!
|
|
HEV has a low mortality rate except in which group?
|
pregnant women
|
|
What viral hepatitis infections are transmitted fecal-oral?
|
HAV and HEV
(the VOWELS hit the BOWELS) |
|
Where is HEV endemic?
|
<b>Asia</b>, India, Africa, Central America
|
|
Which hepatitis virus will show the shortest amount of transaminase elevation time?
|
HAV
|